Sandy Spring Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $24.8K | Sell |
92
-5
| -5% | -$1.35K | ﹤0.01% | 695 |
|
|
2024
Q4 | $22.8K | Sell |
97
-9
| -8% | -$2.12K | ﹤0.01% | 724 |
|
|
2024
Q3 | $29.2K | Hold |
106
| – | – | ﹤0.01% | 697 |
|
|
2024
Q2 | $25.8K | Hold |
106
| – | – | ﹤0.01% | 705 |
|
|
2024
Q1 | $15.8K | Buy |
106
+31
| +41% | +$4.63K | ﹤0.01% | 779 |
|
|
2023
Q4 | $14.4K | Hold |
75
| – | – | ﹤0.01% | 765 |
|
|
2023
Q3 | $13.3K | Hold |
75
| – | – | ﹤0.01% | 771 |
|
|
2023
Q2 | $14.2K | Hold |
75
| – | – | ﹤0.01% | 773 |
|
|
2023
Q1 | $15K | Hold |
75
| – | – | ﹤0.01% | 752 |
|
|
2022
Q4 | $17.8K | Buy |
+75
| New | +$17.8K | ﹤0.01% | 720 |
|
|
2020
Q3 | – | Sell |
-25
| Closed | -$4K | – | 926 |
|
|
2020
Q2 | $4K | Buy |
+25
| New | +$4K | ﹤0.01% | 776 |
|